Rethinking primary prevention of atherosclerosis-related diseases

被引：80
作者：
Napoli, Claudio
Lerman, Lilach O.
de Nigris, Filomena
Gossi, Mario
Balestrieri, Maria Luisa
Lerman, Amir
机构：
[1] Univ Naples 2, Sch Med 1, Dept Gen Pathol, I-80134 Naples, Italy
[2] Univ Naples 2, Sch Med 1, Excellence Res Ctr Cardiovasc Dis, I-80134 Naples, Italy
[3] Boston Univ, Dept Med, Boston, MA 02215 USA
[4] Boston Univ, Whitaker Cardiovasc Inst, Boston, MA 02215 USA
[5] Mayo Clin & Mayo Fdn, Coll Med, Div Cardiovasc Dis, Rochester, MN 55905 USA
[6] Mayo Clin & Mayo Fdn, Coll Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA
[7] Univ Salerno, Dept Pharmacol Sci, I-84100 Salerno, Italy
来源：
CIRCULATION | 2006年 / 114卷 / 23期
关键词：
aging; atherosclerosis; inflammation; prevention;
D O I：
10.1161/CIRCULATIONAHA.105.570358
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2517 / 2527
页数：11
相关论文
共 118 条
  • [91] KUOPIO ATHEROSCLEROSIS PREVENTION STUDY (KAPS) - A POPULATION-BASED PRIMARY PREVENTIVE TRIAL OF THE EFFECT OF LDL LOWERING ON ATHEROSCLEROTIC PROGRESSION IN CAROTID AND FEMORAL ARTERIES
    SALONEN, R
    NYYSSONEN, K
    PORKKALA, E
    RUMMUKAINEN, J
    BELDER, R
    PARK, JS
    SALONEN, JT
    [J]. CIRCULATION, 1995, 92 (07) : 1758 - 1764
  • [92] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
    Sever, PS
    Dahlöf, B
    Poulter, NR
    Wedel, H
    Beevers, G
    Caulfield, M
    Collins, R
    Kjeldsen, SE
    Kristinsson, A
    McInnes, GT
    Mehlsen, J
    Nieminen, M
    O'Brien, E
    Östergren, J
    [J]. LANCET, 2003, 361 (9364) : 1149 - 1158
  • [93] PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
    SHEPHERD, J
    COBBE, SM
    FORD, I
    ISLES, CG
    LORIMER, AR
    MACFARLANE, PW
    MCKILLOP, JH
    PACKARD, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) : 1301 - 1307
  • [94] Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births
    Smith, GCS
    Pell, JP
    Walsh, D
    [J]. LANCET, 2001, 357 (9273) : 2002 - 2006
  • [95] AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update - A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
    Smith, SC
    Blair, SN
    Bonow, RO
    Brass, LM
    Cerqueira, MD
    Dracup, K
    Fuster, V
    Gotto, A
    Grundy, SM
    Miller, NH
    Jacobs, A
    Jones, D
    Krauss, RM
    Mosca, L
    Ockene, I
    Pasternak, RC
    Pearson, T
    Pfeffer, MA
    Starke, RD
    Taubert, KA
    [J]. CIRCULATION, 2001, 104 (13) : 1577 - 1579
  • [96] Spinler SA, 2001, ANN PHARMACOTHER, V35, P589
  • [97] Primary prevention of coronary heart disease in women through diet and lifestyle.
    Stampfer, MJ
    Hu, FB
    Manson, JE
    Rimm, EB
    Willett, WC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (01) : 16 - 22
  • [98] STARY HC, 1989, ARTERIOSCLEROSIS, V9, pI19
  • [99] Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime
    Steinberg, D
    [J]. NATURE MEDICINE, 2002, 8 (11) : 1211 - 1217
  • [100] Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
    Stephens, NG
    Parsons, A
    Schofield, PM
    Kelly, F
    Cheeseman, K
    Mitchinson, MJ
    Brown, MJ
    [J]. LANCET, 1996, 347 (9004) : 781 - 786
3456789101112